016 Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage
- Neurosurgery, University of Washington, Seattle, Washington, USA
Introduction: Among the sequelae of aneurysmal SAH are vasospasm and hydrocephalus. This study aims to assess whether intraventricular tissue plasminogen activator (tPA) results in fewer angioplasties and/or CSF shunting procedures.
Methods: 41 patients (group A, Hunt and Hess (HH) 3–5) from 2007 to 2008 received intraventricular tPA and lumbar drainage for a minimum of 5 days (range 5–7 days) and were compared …